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Abstract
In guiding hES cell technology toward the clinic, one key issue to be addressed is to culture and maintain hES cells much
more safely and economically in large scale. In order to avoid using mouse embryonic fibroblasts (MEFs) we isolated human
fetal liver stromal cells (hFLSCs) from 14 weeks human fetal liver as new human feeder cells. hFLSCs feeders could maintain
hES cells for 15 passages (about 100 days). Basic fibroblast growth factor (bFGF) is known to play an important role in
promoting self-renewal of human embryonic stem (hES) cells. So, we established transgenic hFLSCs that stably express
bFGF by lentiviral vectors. These transgenic human feeder cells — bFGF-hFLSCs maintained the properties of H9 hES cells
without supplementing with any exogenous growth factors. H9 hES cells culturing under these conditions maintained all
hES cell features after prolonged culture, including the developmental potential to differentiate into representative tissues
of all three embryonic germ layers, unlimited and undifferentiated proliferative ability, and maintenance of normal
karyotype. Our results demonstrated that bFGF-hFLSCs feeder cells were central to establishing the signaling network
among bFGF, insulin-like growth factor 2 (IGF-2), and transforming growth factor b (TGF-b), thereby providing the
framework in which hES cells were instructed to self-renew or to differentiate. We also found that the conditioned medium
of bFGF-hFLSCs could maintain the H9 hES cells under feeder-free conditions without supplementing with bFGF. Taken
together, bFGF-hFLSCs had great potential as feeders for maintaining pluripotent hES cell lines more safely and
economically.
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Introduction
Human embryonic stem (hES) cells are pluripotent cells derived
from the inner cell mass of blastocyst-stage human embryos [1,2].
They can be expanded indefinitely as undifferentiated cells for
extended periods of time, and possess the capacity to generate all
cell types in the body. To date, many of the studies have
highlighted the success in differentiating cell populations from hES
cells for cell replacement therapy [3,4]. However, in guiding hES
cell technology toward the clinic, one key issue to be addressed is
to culture and maintain hES cells much more safely and
economically in large scale. hES cells are most commonly
maintained on inactivated mouse embryonic fibroblasts (MEFs)
feeders in medium supplemented with knockout serum-replace-
ment (KSR) together with basic fibroblast growth factors (bFGF,
or FGF 2). These xeno-support systems run the risk of cross-
transfer of animal pathogens from the animal feeder. One example
is hES cells cultured with animal products that express Neu5Gc, as
a nonhuman sialic acid that triggers an immunogenic response [5].
In order to avoid the use of MEFs, human feeders has been used
as an alternative method to maintain hES cells, including
embryonic fibroblasts, adult fallopian tube epithelium [6], bone
marrow stromal cells [7], foreskin fibroblasts [8], human cell lines
(D551/CCL-10, CCL-2552), adult skin cells [9], and placenta cells
[10]. But recently, Rajala et al. test nine previously reported xeno-
free culture media formats, and conclud that none could maintain
the undifferentiated growth of hES cells [11]. So more effective
human feeder cells should be selected by comparing each type of
feeder cell for their capability to support the growth and
maintenance of hES cells. hES cells established on the most
effective human feeder cells will apparently promote the
development of cell-based therapies.
The other systems to avoid using MEFs as feeders is to use a
feeder-free environment that cultures hES cells in special media
supplemented with Matrigel matrix [12]or fibronectin [13].
However, some require culture on Matrigel but this contains a
variety of extracellular matrix (ECM) components, most likely
associated with an ill-defined mixture of growth factors [13,14,15].
Recently, successful attempts have been made to develop
chemically defined culture medium [16,17,18,19]. In the most
present study, the authors introduce a defined serum free medium,
hESF9, in which bFGF was the only protein components [19].
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of the chemically defined medium. Moreover, it is likely that
feeder-free culture are not optimal for developing transplantable
hES cell derivative, for feeder-free cultures usually display a higher
degree of spontaneous differentiation than conventional culture.
And feeder-free systems, using bFGF and other additional growth
factors, will significantly increase the cost of the hES cell culture.
So, it is not suitable to use in large scale expansion of hES cells for
clinical applications. For the time being, the use of feeder cells is
still the safest and most cost-effective option to derive and
propagate stable hES cells.
Despite the evolution of these culture conditions and the addition
of several factors, all require supplementation with bFGF to sustain
hES cell potential. bFGF appears to be of similar importance for
hES cells self-renewal as leukemia inhibitory factor (LIF) is for
mouse ES cells [20]. But the basis to using bFGF to maintain hES
cells still remains unknown. In a previous study, very high
concentrations of bFGF (up to 100 ng/ml) was used to maintain
hES cells [21], this suggests that either bFGF is operating through
an receptor that it is relatively unstable or inefficiently presented to
the cells in the culture conditions used. On the other hand, it is
supposed that bFGF acts on MEFs to release supportive factors and
to reduce differentiation- inducing activity. It is suggested that that
bFGF, at least in part, promotes self-renewal of hES cells by
modulating the expression of transforming growth factor b (TGF-b)
ligands, which, in turn, act on hES cells in autocrine manner [22].
In a most present study, insulin-like growth factor 2 (IGF-2) is
expressed by autologously derived hES cell fibroblast-like cells
(hdFs) in response to bFGF, and alone was sufficient in maintaining
hES cell cultures. This study establishes that hdFs produced by hES
cells themselves define the stem cell niche of pluripotent human
stem cells. The study reveals a previously unappreciated but
essential celluar interplay that establishes a paracrine signaling as
being required for pluripotency of hES cells [23]. So, it would be
possible to establish more effective hES cell culture system by
mimicking the stem cell niche for pluripotency.
In the present study, we had now investigated the culture of H9
hES cells on a new human feeder cells—human fetal liver stromal
cells (hFLSCs). The new feeder cells permitted H9 hES cells
prolonged culture in an undifferentiated state. In particular, we had
established a transgenic feeder cells—bFGF-hFLSCs that stably
express bFGF by lentiviral systems,which could be used to maintain
H9 hEScellswithoutanyexogenousgrowthfactors. And the bFGF-
hFLSCs specifically express high levels of bFGF and IGF-2, which
are the key factor supports hES cells in culture. And hES cells are
successfully maintained feeder-free with conditioned medium of
bFGF-hFLSCs (bFGF-hFLSCs-CM). Thus, bFGF-hFLSCs were a
novelpopulationthatwascapableofsupportinghEScellsexpansion
more effectively and economically. And also the new culture system
could be used as an in vitro model to study comprehensive
mechanisms of hES cell self-renewal and pluripotency.
Materials and Methods
Isolation of hFLSCs
hFLSCs were obtained from 14 weeks human fetal liver tissues
as described previously [24]. Human tissue collection for research
purpose was approved by Research Ethics Committee of Beijing
Institute of Transfusion Medicine. Pregnant women gave written
consent for clinical procedure and research use of the embryonic
tissues in accordance with the Declaration of Helsinki. hFLSCs
were cultured in a medium comprising 45% Dulbecco’s modified
Eagle’s medium (DMEM, Sigma-Aldrich, St. Louis), 45%
DMEM/F12 (Sigma-Aldrich), and supplemented with 10% FCS
(fetal calf serum; Gibco, Grand Island, NY). Briefly, hFLSCs were
prepared using a ceiling culture method. Human fetal liver tissues
were minced into 1 mm
3 pieces, and transferred onto human
gelatin-coated 25-cm
2 flasks. 4 mL of hFLSCs culture medium was
added onto the ceiling surface, and after 5 h the flasks were turned
back over. The tissue pieces were incubated undisturbed for 7 days
at 37uC, allowing the hFLSCs to migrate and adhere to the
gelatin-coated surface. Once the primary hFLSCs reached
confluency, the hFLSCs were digested with 0.25% Trypsin
(Sigma-Aldrich) for 5 min at 37uC. After adding hFLSCs medium,
cultures were pipetted into single-cell suspensions, centrifuged,
resuspended, and replated onto new flasks.
Establishment and Characterization of Transgenic hFLSCs
that Overexpressing bFGF
hFLSCs that stably express bFGF were established as previously
described [24]. Briefly, bFGF cDNA was cloned from human
Mesenchymal stem cells (MSCs) using RT-PCR. Then the
amplified human bFGF fragments was ligated into a pBPLV
lentiviral vector plasmids containing eGFP [25] (kindly provided by
Dr. Luigi Naldiai, Vita Salute San Raffaele University, Italy)
(supporting information Fig.S1). The lentiviruseswereassembled in
293-FT cells lines (Invitrogen). hFLSCs were seeded at 5610
5 cells
per 25-cm
2 flasks one day before transduction. The medium was
replaced with virus-containing supernatant supplemented with
4 mg/ml polybrene (Sigma-Aldrich), and incubated for 48 h. After
48 h of transfecction, the eGFP positive hFLSCs that constitutively
expressed bFGF were sorted by fluorescence-activated cell sorting
(FACS) according to the low and high intensity of eGFP expression.
General hES Cell Culture
hES cells (H9; WiCell Research Institute, Madison, WI) were
cultured according to the supplier’s instructions. Briefly, hES cells
were routinely cultured on CD1 MEFs in knockout (KO)-
DMEM/F12 (Invitrogen, Carlsbad, CA) containing 20% KSR(In-
vitrogen), 2 mM L-glutamine, 100 mM nonessential amino acids
(NEAA, Invitrogen), 100 mM b-mercaptoethanol (Invitrogen),
4 ng/mL bFGF (Peprotech, Rocky Hill, NJ) and 0.5% penicillin
and streptomycin. The medium was changed every day.
Culture of hES Cells on hFLSCs and bFGF-hFLSCs
The hFLSCs with or without the bFGF transgene were
irradiated (40 Gy of
60Co-c) within twenty generations and frozen
in liquid nitrogen. Before passaging, the hFLSCs were thawed and
replated into 6 well cell culture plate at the density of 1610
6 per
well to be feeders. After 24 h, the culture medium was replaced
with hES cell culture medium and hES cells could be seeded on
the feeders. hES cells cultured on hFLSCs or bFGF-hFLSCs were
passaged every one week by mechanical harvesting.
hES cell culture medium for hFLSCs feeders was identical to
the medium used in MEFs feeders, and the medium were changed
daily. hES cell culture medium for bFGF-hFLSCs feeders was also
identical to the medium used in MEFs feeders but removal of the
bFGF, and the medium were changed daily by partial medium
changes.
Characterization of hES cells by Flow Cytometry
Single-cell suspensions were made from undifferentiated hES
cells. Stained cells were analysed on a FACS Calibur using Cell
Quest software (BD Biosciences, San Diego). Unconjugated
antibody against Stage-specific embryonic antigen 4 (SSEA4)
(Chemicon, Temecula, CA), tumor-related antigen 60 (TRA-1-60)
(Chemicon), and OCT4 (Chemicon) were used to viably identify
Transgenic Feeders for hESCs
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fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG
(BD Biosciences) for 30 min. Finally, the cells were washed twice
with PBS and analyzed by flow cytometery. Negative controls
represented staining of cells in the absence of primary antibody.
Embryoid Bodies (EBs)-mediated In Vitro Differentiation
of hES Cells Cultured on bFGF-hFLSCs
For EBs formation, H9 hES cells were harvested by treating
with collagenase IV. The clumps of the cells were transferred to 6-
well Ultra-Low Attachment Plate (Corning, NY) in DMEM/F12
containing 20% KSR (Invitrogen), 2 mM L-glutamine, 100 mM
NEAA (Invitrogen), 100 mM-mercaptoethanol (Invitrogen), and
0.5% penicillin and streptomycin. The medium was changed every
other day. After 6 days as a floating culture, EBs were transferred
to gelatin-coated plate and cultured in the same medium for
another 10 days.
Teratoma formation
Approximately 5610
6 H9 hES cells cultured on bFGF-hFLSCs
for 10 passages (about 70 days) with undifferentiated morphology
were subcutaneously injected into the rear leg armpit of 6–8 weeks
old Nonobese Diabetic/Severe Combined Immunodeficiency
(NOD-SCID) mice. About 6–10 weeks after injection, teratoma
formed and were dissected and fixed with 4% paraformaldehyde
overnight. The samples were then cut at a thickness of 10 mm and
transferred to Poly-D-Lysine-coated slides. Sections were exam-
ined histologically after hematoxylin and eosin staining. All the
animal experiments were approved by the Animal Care and Use
Committee of Beijing Institute of Transfusion Medicine.
Immunocytochemistry
Cells were rinsed twice with PBS before fixation with 4%
paraformaldehyde, followed by protein staining before permeabili-
zation with 0.2% Triton X-100 or 100% methanol and staining for
OCT4. Cells were blocked with 10% normal rabbit serum or 10%
normal goat serum at room temperature. Antibodies used were anti-
IGF1R(R&DSystems,Minneapolis),anti-FGFR1(Chemicon),anti-
OCT4 (Chemicon), anti-SSEA-4 (Chemicon), anti-TRA-1-60
(Chemicon), anti-TRA-1-81 (Chemicon), anti-bIII-TUBULIN (BD
Biosciences), anti-a-SMA (BD Biosciences), and anti-AFP (Sigma-
Aldrich). Cells were incubated with primary antibodies followed by
secondary detection with FITC-conjugated goat anti-mouse IgG
(BD Biosciences), or FITC-conjugated rabbit anti-goat IgG (BD
Biosciences), or TRITC-conjugated goat anti-mouse IgG (BD
Biosciences). Nucleuses were stained with 1 mg/ml DAPI (Sigma-
Aldrich). Fluorescence was visualized using Olympus IX70 (Olym-
pus, Tokyo) fluorescence microscope, and images were recorded
using a digital SPOT RT3 CCD camera (Diagnostic Instruments
inc., Sterling Heights, MI) using version 4.5 SPOT software.
Feeder-free maintenance of hES cells in bFGF-hFLSCs-
CM)
hES cells lines H9 were maintained in a feeder-free culture over
matrigel-coated (BD Biosciences) six-well plate in bFGF-hFLSCs-
CM. bFGF-hFLSCs-CM was prepared and collected as described
in detail for MEF-CM [12,26]. The basal media used to prepare the
CM consisted of 80% KO-DMEM/F12 supplemented with 20%
KSR, 1% NEAA, 1 mM L-glutamine, 0.1 mM b-mercaptoethanol.
H9 hES cells was maintained feeder-free for 10–15 passages (about
70–100 days). The media was changed daily and the hES cells
cultures were split (1:3) using collagenase IV. H9 hES cells were also
cultured under feeder free conditions using MEF-CM [26] and
mTeSR1(StemCell Technologies, Vancouver, BC, Canada) follow-
ing the manufacturer’s instructions.
Reverse Transcription-Polymerase Chain Reaction
Analysis
Total RNA was extracted by TRIzol reagent (Invitrogen)
according to the manufacturer’s instructions. 1 mg RNA was then
reverse-transcribed into cDNA by Avian Myeloblastosis Virus
(AMV) reverse transcriptase (Takara Bio, Shiga, Japan). PCR was
performed with rTaq polymerase (TaKaRa). An aliquot of PCR
products was analyzed on 1.5% ethidium bromide-stained
agarose. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
or b-actin was used as a housekeeping gene to evaluate and
compare quality of different cDNA samples.
RT-PCR Primer Sequences
The following primer pairs were used for the amplification of
target mRNAs: Oct-4 (123 base pair [bp]), forward 59- AAC CTG
GAG TTT GTG CCA GGG TTT-39 and reverse 59- TGA ACT
TCA CCT TCC CTC CAA CCA-39; Sox-2 (151 bp), forward 59-
GGG AAA TGG GAG GGG TGC AAA AGA GG-39 and
reverse 59- TTG CGT GAG TGT GGA TGG GAT TGG TG-
39; Nanog (216 bp), forward 59- CAG AAG GCC TCA GCA
CCT-39 and reverse 59- CTG TTC CAG GCC TGA TTG TT-
39; HCG (510 bp), forward 59- CAG GGG ACG CAC CAA GGA
TG-39 and reverse 59- GTG GGA GGA TCG GGG TGT CC-39;
CK18 (233 bp), forward 59- AGC TCA ACG GGA TCC TGC
TGC ACC TTG-39 and reverse 59- CAC TAT CCG GCG GGT
GGT GGT CTT TTG-39; AFP (281 bp), forward 59- GAA TGC
TGC AAA CTG ACC ACG CTG GAA C-39 and reverse 59-
TGG CAT TCA AGA GGG TTT TCA GTC TGG A-39;
Brachyury (144 bp), forward 59- TGT CCC AGG TGG CTT
ACA GAT GAA-39 and reverse 59- GGT GTG CCA AAG TTG
CCA ATA CAC-39; PAX6 (317 bp), forward 59- ACC CAT TAT
CCA GAT GTG TTT GCC CGA G-39 and reverse 59- ATG
GTG AAG CTG GGC ATA GGC GGC AG-39; GFAP (328 bp),
forward 59- GGC CCG CCA CTT GCA GGA GTA CCA GG-
39 and reverse 59- CTT CTG CTC GGG CCC CTC ATG AGA
CG-39; bFGF (486 bp), forward 59- AAC TGC AGA TGC CAG
CCG GGA GCA TC-39 and reverse 59- ACG CGT CGA CTC
AGC TCT TAG CAG ACA TTG GAA GAA-39; IGF-1 (184 bp),
forward 59- GCT GGT GGA TGC TCT TCA GTT C-39 and
reverse 59- AGC TGA CTT GGC AGG CTT GAG-39; IGF-2
(150 bp), forward 59- TTG CTC TAC CCA CCC AAG AC-39
and reverse 59- GAT GGA ACC TGA TGG AAA CG-39; TGF-
b1 (221 bp), forward 59- GCG TGC TAA TGG TGG AAA C-39
and reverse 59- GCT GAG GTA TCG CCA GGA AT-39; IGF1
receptor (99 bp), forward 59- CCA AAG ACA AAA TCC CCA
TC-39 and reverse 59- CTT TCT CCC CAC CAC ACA C-39;
FGF receptor 1 (119 bp), forward 59- GGC TAC AAG GTC
CGT TAT GC-39 and reverse 59- TGG TAT GTG TGG TTG
ATG CTG-39; b-actin (222 bp), forward 59- GAT CCA CAT
CTG CTG GAA GG-39 and reverse 59- AAG TGT GAC GTT
GACATC CG-39; GAPDH (325 bp), forward 59- TGT CAT
CAA TGG AAA TCC CAT CAC C-39 and reverse 59- CAT
GAG TCC TTC CAC GAT ACC AAA-39.
Protein Extraction and Western Blotting
Protein extracts were obtained using RIPA lysis buffer (50 mM
Tris-HCl pH 7.4; 150 mM NaCl; 1% NP-40; 0.1% SDS; 0.5%
Na-deoxycholale) with protease inhibitor (Merk Chemicals,
Darmstadt, Germany). Cell lysates were cleared at 12,000 g for
10 minutes at 4uC. Equal amounts of proteins in the supernatants
Transgenic Feeders for hESCs
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membrane (Bio-Rad, Hercules, CA). Membranes were blocked
with 4% non-fat milk (Bio-rad)/TBS-T and incubated with an
anti-bFGF antibody or anti-IGF-2 antibodies (all from R&D
Systems) followed by horseradish peroxidase (HRP)-conjugated
secondary antibodies and visualized with ECL (Santa Cruz
Biotechnology, Santa Cruz, CA) detection. Chemoluminescence
was visualized on an x-ray film.
Enzyme-linked Immunosorbent Assays
Free human bFGF was determined with the FGF basic ELISA
kit (R&D Systems). Assays were performed according to the
manufacturer’s recommended protocol. Protein extracted from
culture supernatants were standardized for total protein
content using the BCA Protein Assay kit (Pierce, Rockford, IL)
before analysis. Results are representative of four independent
experiments.
Karyotype Analysis
Karyotype analyses of H9 hES cells cultured on hFLSCs and
bFGF-hFLSCs were carried out at passages 15 (about 100 days)
using the standard G-banding procedure. The karyotype analyses
were done at the Beijing Institute of Radiation Medicine,
Cytogenetics Laboratory (Beijing, China).
Figure 1. Morphology and characterization of H9 hES cells grown on hFLSCs. (A): Derivation of hFLSCs by ceiling culture method. (B):
hFLSCs show typical fibroblast morphology. (C): Morphology of H9 hES cells grown on hFLSCs. (D): RT-PCR analysis of H9 hES cells grown on hFLSCs
for 10 passages (about 70 days). 1: hFLSCs feeder cells, 2: H9 hES cells cultured on MEF, H9 hES Cells cutred on hFLSCs. (E): Cell phenotype analysis of
H9 hES cells that cultured on hFLSCs for 10 passages (about 70 days) by flow cytometry.(F): H9 hES cells grown on hFLSCs for 15 passages (about 100
days) stained with antibody recognizing the OCT-4 and SSEA-4. Nuclei were stained with DAPI (blue). Bars: (A-C, F) 100 mm.
doi:10.1371/journal.pone.0014457.g001
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hFLSCs Used as Feeder Cells for Maintenance of H9 hES
Cells
We isolated and cultured hFLSCs from 14 weeks human fetal
liver. About one week in culture the stromal cells migrated from the
border of the tissue clumps (Fig. 1A), and it took two weeks for the
cells to become confluent. After the primary and three subsequent
passages, hFLSCs were adherent to be fusiform shape and highly
uniform in morphology (Fig. 1B). As hFLSCs are propagated in
culture for more than 30 passages (about 90 days), there are no
obviously cell morphology changes. And then the irradiated
hFLSCs were used for feeder cells to maintain H9 hES cells. Thus
far,H9cells were grown on hFLSCs forover15 passages (about100
days). We found that H9 hES cells colonies grown on hFLSCs were
dense and compact, and they exhibited the typical morphology of
hES cells (Fig. 1C). RT-PCR analysis showed positive expression of
OCT-4, SOX-2 (Fig. 1D) when growingon hFLSCs for 10 passages
(about 70 days). Flow cytometry analysis revealed that H9 hES cells
grownonhFLSCsexpressedhESspecificmarkersOCT-4,SSEA-4,
andTRA-1-60(Fig.1E).Immunocytochemicalanalysisalsoshowed
that H9 hES cells cultured on hFLSCs for 15 passages (about 100
days) expressed markers typical of hES cells, such as OCT-4 and
SSEA-4 (Fig. 1F). The H9 hESCs cultured on hFLSCs had
no differences with cultured on MEF (supporting information
Fig. S2A–C) Karyotyping of the hES cells showed that H9 hES cells
grown on hFLSCs had normal female karyotype (supporting
information Fig. S3).
Maintenance of H9 hES cells on bFGF-hFLSCs Feeder
Cells
We have established the bFGF-hFLSCs by lentiviral system in
our previous study [24]. After having been transfected with bFGF,
the hFLSCs were sorted by FACS according to the intensity of
eGFP expression (supporting information Fig. S4). The transduced
hFLSCs with high eGFP expression were named as bFGF-hFLSCs
and used as new feeder cells for maintenance of hES cells. As
bFGF-hFLSCs were propagated in culture, there were also no
obviously cell morphology changes. Flow cytometry analysis was
used to characterize cell surface markers of bFGF-hFLSCs,
showing that the bFGF-hFLSCs were positive for some stromal
progenitor markers, such as CD29, CD44, CD71, CD90, and
CD105, but negative for CD34 and CD45 (supporting informa-
tion Fig. S5), which was similar to the untransfected hFLSCs [24].
bFGF-hFLSCs maintained normal male karyotypes after 20
passages (about 60 days) (supporting information Fig. S6).
The irradiated bFGF-hFLSCs feeder cells showed the typical
mesenchymal cell shape, and almost all cells expressed the eGFP
(Fig. 2A). To determine the expression of bFGF in bFGF-hFLSCs,
western blotting was used to detect the expression level of bFGF
Figure 2. Morphology and identification of bFGF over-expressing hFLSCs feeder cells. (A): eGFP expression of c-irradiated bFGF-hFLSCs
imaged by fluorescence microscope. Bars: 100 mm. (B): Western blotting analysis indicated that bFGF highly expressed in c-irradiated bFGF-hFLSCs.
(lane 1) c-irradiated hFLSCs transfected with control vectors; (lane 2) c-irradiated bFGF- hFLSCs; (lane 3) A half amount of the lane 2. (C): The enzyme-
linked immunosorbent assay (ELISA) to bFGF showed that bFGF-hFLSCs could stably secret bFGF for one week. Values are presented as means 6 SD,
n=4.
doi:10.1371/journal.pone.0014457.g002
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high bFGF expression in bFGF-hFLSCs feeders. To measure
bFGF in cell culture supernates, the quantikine bFGF immuno-
assay kit was used to determine values accurately. The results
showed that soluble bFGF in culture medium of c-irradiated
bFGF-hFLSCs maintained in high level in about one week
(Fig. 2C). The secreting bFGF from bFGF-hFLSCs feeder cells
might replace the exogenous bFGF in hES cell culture.
To test whether bFGF-hFLSCs support undifferentiated growth
of hES cells without supplementing with exogenous bFGF, we
culturedH9hEScellsonbFGF-hFLSCs.Indeed,mostH9hEScells
cultured with bFGF-expressing hFLSCs were maintained in an
undifferentiated state. Undifferentiated hES colonies also could be
found under fluorescence conditions for eGFP detection (Fig. 3A).
RT-PCR analysis showed positive expression of OCT-4, SOX-
2 (Fig. 3B) when H9 hES cells grown on bFGF-hFLSCs for 10
passages (about 70 days). Karyotype analysis showed that H9 hES
cells grown on bFGF-hFLSCs had normal female karyotypes
(Fig. 3C). The new culture system proved of supporting the culture
of H9 hES cells and the expression of the specific markers OCT-4,
SSEA-4, TRA-1-60 and TRA-1-81 was similar to cells grown on
MEFs (Fig. 4). Currently, hES cells are commonly cultured on
MEF feeders with 4 ng/ml exogenous bFGF in culture conditions.
Our data suggested that without the exogenous bFGF, the fetal
liver stromal cells with the bFGF transgene provided an
environment to maintain hES cells for a long culture time.
Embryoid Body-Mediated Differentiation of hES Cells
Cultured on bFGF-hFLSCs
The hES cells retained the capacity for extensive differentiation
as indicated by analysis of ectoderm, mesoderm, and endoderm
marker gene expression following EB formation. To determine the
differentiation ability of H9 hES cells cultured on bFGF-hFLSCs in
vitro, we used floating cultivation to form EBs [27]. After 6 days in
suspension culture, H9 hES cells formed ball-shaped EBs (Fig. 5A).
The EBs did not contain the eGFP-positive-hFLSCs feeder cells by
examining with fluorescence microscopy. We transferred EBs to
gelatin-coated plates and continued cultivation for another 10 days
(Fig. 5B). Attached cells showed various types of morphologies, such
as those resembling epithelial cells and fibroblast like cells (Fig. 5C,
D). RT-PCR confirmed that these differentiated cells expressed
human chorionic gonadotrophin (HCG, a marker of extraembry-
onic trophoblast), a-fetoprotein (AFP, endoderm), cytokeratin 18
(CK 18, endoderm), BRACHYURY (mesoderm), and paired box 6
(PAX6, ectoderm), glial fibrillary acidic protein (GFAP, ectoderm)
(Fig. 5E). In contrast, expression of OCT4 and SOX-2 was almost
undetectable (Fig. 5E). The in vitro differentiation capability of H9
hES cells was similar to that cultured on MEF (supporting
information Fig.S2D).Immunocytochemistrydetected cellspositive
for bIII-tubulin (a marker of ectoderm), a-smooth muscle actin (a-
SMA, mesoderm), and AFP (endoderm) (Fig. 5F). These data
demonstrated that hES cells could differentiate into three germ
layers in vitro. We subsequently tested long-term culture of H9 hES
cells to 15 passages (about 100 days), morphologies of undifferen-
tiated hES cell colonies were maintained as those cultured on MEFs
feeders. Additionally, H9 hES cells cultured on bFGF-hFLSCs for
10 passages (about 70 days) were able to form teratoma comprising
cell lineages of three embryonic germ layers in vivo in NOD-SCID
mice (Fig. 5G).
The FGF and IGF Related Receptors Expression in the hES
and hFLSCs Culture
There are four FGF receptors (FGFR1–4). bFGF is related to
FGFR1, which accounts for the high affinity of bFGF binding sites
in the nucleus and cytoplasm [28]. Previous study suggest that
FGF receptors may be important to hES cell culture systems, but
Figure 3. Characterization and karyotyping of H9 hES cells cultured on bFGF-hFLSCs feeder cells. (A): The H9 hES cells cultured on
bFGF-hFLSCs imaged by fluorescence microscope. Bars: 100 mm. (B): RT-PCR analysis of H9 hES cells grown on bFGF-hFLSCs for 10 passages (about 70
days). 1: bFGF-hFLSCs feeder cells, 2: H9 hES cells cultured on MEF, H9 hES Cells cutred on bFGF-hFLSCs. (C): H9 hES cells grown on bFGF-hFLSCs for
15 passages (about 100 days) showed normal female karyotype (46, XX).
doi:10.1371/journal.pone.0014457.g003
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human stem cells. However, IGF1R expression correlates with
pluripotent stem cell markers and thereby underscores both the
uniqueness and general importance of the IGF-2/IGF1R axis in
hES cell lines [23]. So, in the present study, we investigated
expression of FGFR1 and IGF1R to confirm the link between
bFGF and IGF in the H9 hES cells and hFLSCs culture. As shown
in Fig. 6A, the hFLSCs expressed FGFR1, and didn’t express
IGF1R. We also observed that IGF1R expressed exclusively
within H9 hES cell colonies (Fig. 6B), while FGFR1 expression
was limited to cells surrounding the H9 hES cell colonies (Fig. 6C).
These results provided another example of bFGF’s role in the stem
cell niche underlining human feeder cells indirectly regulating hES
cells.
bFGF-hFLSCs Expressed IGF-2 and Other Related Factors
Since bFGF is known to regulate IGF-1 [29] and IGF-2 [30],
we examined the relative expression level of IGF-2 genes in
bFGF-hFLSCs by RT-PCR and western blotting. The results
showed that both the expression of bFGF and IGF-2 mRNA
highly increased in bFGF-hFLSCs (Fig. 7A). Western blotting
also showed that the IGF-2 protein was highly induced in bFGF-
hFLSCs (Fig. 7B). These data indicated that bFGF-hFLSCs
produced adequate amounts of endogenous IGF-2 to maintain
hES cells. To determine whether bFGF influences not only
IGF-2, but also other related factors, we investigated the
expression of IGF-1, TGF-b1, IGF1R and FGFR1 by RT-PCR
in bFGF-hFLSCs. TGF-b1 expression was shown to be induced
by bFGF transfection. These data suggested that bFGF-hFLSCs
produced TGF-b1 factors required by hES cells to maintain an
undifferentiated state. And also FGFR1 and IGF1R expression of
bFGF-hFLSCs was also higher than that of hFLSCs transfected
with control vector.
Feeder-free maintenance of hES cells in bFGF-hFLSCs-CM
Many feeder-free hES cells culture systems is still based on the
use of xenogenic MEF-CM. Only in very recent work have hES
cells been maintained feeder free using chemically defined
medium [16,19]. We therefore sought to determine whether H9
hES cells can be maintained pluripotent and feeder-free in bFGF-
hFLSCs-CM. H9 hES cells were maintained for 15 passages
(about 100 days) feeder-free in bFGF-hFLSCs-CM. No differences
in culture homeostasis were observed among hES cells maintained
in bFGF-hFLSCs-CM versus MEF-CM and mTeSR1. Identical to
H9 hES cells cultured in MEF-CM and mTeSR1, those
maintained in bFGF-hFLSCs-CM retained typical hES cell
morphology and expression of transcription factors Oct4 and
Sox-2 (Fig. 7D). Similarly, both H9 hES cells expressed the the
pluripotency associated surface markers SSEA-4 (Fig. 7E).
Discussion
Here we described a new population of hFLSCs that were
capable of supporting the H9 hES cells expansion in vitro. We had
Figure 4. Immunocytochemistry for OCT-4, SSEA-4, TRA-1-60, TRA-1-81 of the H9 hES cells that cultured on bFGF-hFLSCs for 12
passages (about 80 days). Bars: 100 mm.
doi:10.1371/journal.pone.0014457.g004
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retained stable expression of undifferentiated markers of hES cells,
and a capacity to differentiate to three germ layer cells. We further
showed that hFLSCs over-expressing bFGF could be used as a
new feeder cells to maintain H9 hES cells without supplementing
with any exogenous growth factors. And the conditioned medium
of bFGF-hFLSCs could maintain the H9 hES cells under a feeder-
free conditions without supplementing with bFGF. Our results
Figure 5. In vitro and in vivo differentiation of H9 hES cells cultured on bFGF-hFLSCs for 10 passages (about 70 days). (A): Floating
culture of H9 hES cells at day 6. Bar: 100 mm. (B–D): Images of differentiated cells at day 10 (B), epithelial cells (C), fibroblast like cells (D). Bars: 100 mm.
(E): RT-PCR analysis of various differentiation markers for the three germ layers and extraembryonic trophoblast. (F): Immunocytochemistry of AFP,a -
SMA, and bIII-TUBULIN. Nuclei were stained with DAPI (blue). Bars: 100 mm. (G): Teratoma formation. bFGF-hFLSCs-cultured H9 cells for 10 passages
(about 70 days) form teratoma generating structures representative of three germ layers. Bars: 100 mm.
doi:10.1371/journal.pone.0014457.g005
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IGF1R hFLSCs express FGFR1. And the bFGF-hFLSCs
specifically expressed high levels of bFGF, IGF-2 and other
related factors to support hES cells in culture. We suggested that
bFGF-hFLSCs maintained H9 hES cells by establishing a stem cell
niche through which supporting the self-renewal and pluripotency
of hES cells.
Mouse feeder cells are associated with risks such as viral
infection and pathogen transmission when hES cells are used in
clinical trials. Various culture conditions have been developed to
overcome these problems. Previous studies have used certain types
of primary human cells, as well as commercially available cell lines,
as feeder layers [9,31,32,33]. These studies all show that human
feeder cells can be used to support hES cell growth and
miantainenane. In our study, we isolated hFLSCs from 14 weeks
fetal liver tissues, thus probably providing embryonic-like niche for
hES cells. Our results showed that H9 hES cells can be maintained
on hFLSCs feeder cells for over 15 passages (about 100 days).
hFLSCs could be used as a new human feeder cell to support hES
cells expansion in vitro.
One of the improved culture conditions is a feeder-free culture
[12,15]. And several chemically defined culture mediums also are
used to maintain hES cells [17,19,34]. One important issue is that
these culture mediums are so expensive that they can’t be used in
large-scale expansion of hES cells for prospective clinical
applications. It will be very important to find more economical
hES cell culture methods.
As we have known, bFGF remains a necessary growth factor for
the undifferentiated growth of hES cells. It regulates the expression
of TGFb1, Activin A and the BMP4 antagonist which are
important for hES cell growth and self-renewal [22,35]. The fact
that MEF and human feeder cell lines secrete varying amounts of
bFGF may partially explain why different batches of MEFs and
human feeder cell lines support hES cells differently [35]. Cai and
colleagues generate immortalized feeder cells overexpressing
Wnt3a that are supportive of hES cell expansion and pluripotency
maintenance [36]. One fibroblast-like feeder cell line which
differentiated spontaneously from hES cells secreting bFGF
supported hES cell expansion particularly well up to passages 15
[37]. In this study about 11.6660.23 pg/ml of FGF2 is detected in
the germ layer derived fibroblast cells (GLDF) conditioned
medium. These studies indicated that using gene modification
feeder cells might improve the hES cell culture method. Our
results showed that bFGF-hFLSCs secreted much higher bFGF
than in the previous study [37]. We found that the maintenance of
undifferentiated hES cells could be promoted by the bFGF-
hFLSCs without supplementing with growth factors. The hES cell
colonies maintained on bFGF-hFLSCs showed less signs of
morphological differentiation. The hES cells were positive for
the pluripotent markers when maintained on bFGF-hFLSCs. hES
cells were stably passaged for up to 15 passages (about 100 days) by
co-culture with bFGF-hFLSCs.
Expression of bFGF in bFGF-hFLSCs feeder cells made the
hES cell culture more economical where supplemental bFGF is
not needed. It was quite evident that bFGF-hFLSCs cells
presented to hES cell researchers with a novel feeder system for
stable hES cell cultures. bFGF-hFLSCs were eased to culture for
large scale, and enabled the development of goods mamufacturing
Figure 6. Immunocytochemistry for FGFR1 and IGF1R of the hFLSCs (A) and hES cells that cultured on hFLSCs (B,C). Nuclei were
stained with DAPI (blue). Bars: 100 mm.
doi:10.1371/journal.pone.0014457.g006
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could be an efficient alternative and useful to support the
derivation and culture of new hES cell lines for clinical
applications as comparable to hES cells cultured on MEFs.
Several recent studies have shown that IGF-2 play an important
role in maintenance of hES cells [23,34,38]. IGF-2 has been
suggested to play important roles in embryonic but not adult
growth and development [39,40]. IGF-2 has also been used to
Figure 7. H9 hES cells could be maintained feeder-free with bFGF-hFLSCs-CM. (A): RT-PCR analysis of bFGF and IGF-2 gene expression in
hFLSCs and bFGF-hFLSCs. (B): Western blotting analysis of IGF-2 gene expression in hFLSCs and bFGF-hFLSCs. (C): RT-PCR analysis of bFGF and IGF-2
related gene expression in hFLSCs and bFGF-hFLSCs. (D): RT-PCR analysis of H9 hES cells grown on MEF-CM, mTeSR1 and bFGF-hFLSCs-CM for 10
passages (about 70 days). (E): Immunophenotypic characterization of H9 hES cells maintained feeder-free with MEF-CM, mTeSR1 and bFGF-hFLSCs-
CM for 10 passages (about 70 days). Nuclei were stained with DAPI (blue). Bars: 250 mm.
doi:10.1371/journal.pone.0014457.g007
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ated stem cells from the inner cell mass in culture [41,42]. In a
previous study [43], the author identified IGF-2 expressed in a
novel fetal liver cell populations as a novel stem cell growth factor.
Because IGF-2 has pleiotropic effects, it may have the potential to
act on a broader spectrum of stem cells, both ex vivo and in vivo.
One study focus on FGF receptor expression profiles in hES cell
cultures, and suggest that bFGF may stimulate undifferentiated
hES cell proliferation directly or indirectly [44]. In another study,
a simultaneous interrogation of 42 receptor tyrosine kinases
(RTKs) in hES cells following stimulation with MEF conditioned
medium (CM) reveal rapid and prominent tyrosine phosphoryla-
tion of insulin receptor (IR) and IGF1R [34]. In the most recent
study, the authors showed that hES cells spontaneously and
continuously differentiate into hdFs, providing a continuous source
of endogenous hES cell supportive factors, including IGF-2 and a
host of TGF-b family of factors and other ligands [23]. On the
whole, these studies demonstrate a direct role of the IGF-2/
IGF1R axis on hES cell self-renewal and pluripotency.
In the present study, we suggested bFGF and IGF-2 as the
principal growth factor produced by bFGF-hFLSCs that supports
expansion of H9 hES cells. And our results showed that hFLSCs
expressed FGFR1, which could be stimulated by the bFGF
secreted by bFGF-hFLSCs through autocrine and paracrine
model. And after transducing with bFGF, the expression of
IGF1R, FGFR1, and TGF-b1 in bFGF-hFLSCs was much higher
than in hFLSCs. This positive model made bFGF-hFLSCs express
sufficient IGF-2 and TGF-b1 to support growth and maintenance
of hES cells through IGF-2/IGF1R axis and other undefined
signal pathways. bFGF-hFLSCs feeder cells were central to
establishing the signaling network among bFGF, IGF-2, and
TGF-b, and thereby probably providing the framework in which
hES cells were instructed to self-renew or to differentiate.
The concept that a regulatory niche creates an essential and
supportive microenvironment for stem cells has been well
established in several organisms and lineages [45]. In our previous
study, we have used hFLSCs expressing hypoxia inducible factor
1a (HIF-1a) to maintain self-renewal and pluripotency of hES cells
[46]. Our present study also provided evidences that gene
modified hFLSCs generated a stem cell niche in vitro that could
support the growth and pluripotency of H9 hES cells. Our in vitro
hES cells culture system using bFGF-hFLSCs as feeder cells
provided an opportunity to elucidate the fundamental elements
tightly controlling hES cell self-renewal and pluripotency.
In our present study, we aimed at determining whether the hES
cells can be maintained pluripotent using bFGF-hFLSCs-CM
rather than xenogenic MEF-CM. Similar to feeder-free culture in
MEF-CM and mTeSR1, H9 hES cells can be equally maintained
stable and pluripotent for over 15 passages (about 100 days). H9
hES cells maintained in bFGF-hFLSCs-CM without supplement-
ing with bFGF retained typical morphology, expression of surface
markers and transcription factors associated with pluripotency
The conditioned medium of bFGF-hFLSCs could be used to
develop a new hES cell feeder-free culture condition.
In conclusion, we isolated a new human feeder cell for
maintenance of H9 hES cells. And then, we established transgenic
cell lines — bFGF-hFLSCs that stably express bFGF, which could
be used as feeder cells culturing H9 hES cells without
supplementing with exogenous growth factors. More importantly
of the bFGF-hFLSCs-CM could maintain H9 hES cell pluripo-
tency in feeder-free culture conditions. bFGF-hFLSCs had great
potential as feeders for maintaining hES cells more safely and
economically.
Supporting Information
Figure S1 The construction of lentiviral vector pBPLV.
Found at: doi:10.1371/journal.pone.0014457.s001 (0.88 MB TIF)
Figure S2 H9 hES cells cultured on MEF. (A): Morphology of
MEF. Bars =100 mm. (B): Morphology of H9 hES cells cultured
on MEF. Bars =100 mm. (C): Immunophenotypic characteriza-
tion of H9 hES cells cultured on MEF. Nuclei were stained with
DAPI (blue). Bars: 100 mm. (D): In vitro differentiation of H9 hES
cells cultured on MEF. RT-PCR analysis of various differentiation
markers for the three germ layers and extraembryonic trophoblast.
Found at: doi:10.1371/journal.pone.0014457.s002 (2.50 MB TIF)
Figure S3 Karyotype analysis of H9 hES cells expanded on
hFLSCs feeder cells for 15 passages (about 100 days) represented
normal 46, XX karyotype.
Found at: doi:10.1371/journal.pone.0014457.s003 (1.12 MB TIF)
Figure S4 Transfected hFLSCs with low and high eGFP
expression were sorted by fluorescence-activated cell sorting
(FACS). The zonation of the selected transfected hFLSCs, P3
reprsented the hFLSCs with low eGFP expression, P4 represented
hFLSCs with high eGFP expression.
Found at: doi:10.1371/journal.pone.0014457.s004 (4.29 MB TIF)
Figure S5 Flow cytometry analysis of bFGF-hFLSCs for the
presence of CD29, CD44, CD90, and CD105, and negative for
CD11b, CD34, CD45 and CD144. The green line represented the
staining with the isotype control, and the red line showed staining
with specific antibodies.
Found at: doi:10.1371/journal.pone.0014457.s005 (1.02 MB TIF)
Figure S6 Karyotype analysis of bFGF-hFLSCs for 20 passages
(about 60 days) represented normal 46, XY karyotype.
Found at: doi:10.1371/journal.pone.0014457.s006 (8.67 MB TIF)
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